General

“Article: A-108 Belgian multicenter study into von Willebrand Disease (B-Will Study): First results” has been added to your cart. View cart

Showing 33–48 of 1897 results

Article: A-103 SYSTEMIC THROMBOLYSIS AND ENDOVASCULAR THROMBECTOMY IN SEVERE ACUTE ISCHEMIC STROKE AFTER DABIGATRAN REVERSAL WITH IDARUCIZUMAB
€2.42 Add to cart
Article: A-103 VALIDATION OF A CHROMOGENIC ASSAY FOR FVIII: C AND FIX: C (CSA) MEASURING AND COMPARISON WITH A CHRONOMETRIC ASSAY (OSA)
€2.42 Add to cart
Article: A-104 THE INTERACTION OF FACTOR V AND TISSUE FACTOR PATHWAY INHIBITOR IN A MYELOMA PATIENT WITH ACQUIRED FACTOR V DEFICIENCY
€2.42 Add to cart
Article: A-105 PEAR1: a novel link between IgE-mediated allergy and cardiovascular disease
€2.42 Add to cart
Article: A-105 PRE-ANALYTICAL STABILITY OF COAGULATION PARAMETERS IN PLASMA STORED AT ROOM TEMPERATURE
€2.42 Add to cart
Article: A-105 THE ROLE OF VON WILLEBRAND FACTOR IN A MALARIA-ASSOCIATED LUNG PATHOLOGY MODEL
€2.42 Add to cart
Article: A-106 DABIGATRAN ETEXILATE IN THE TREATMENT OF LOCALIZED INTRAVASCULAR COAGULOPATHY ASSOCIATED WITH VENOUS MALFORMATIONS
€2.42 Add to cart
Article: A-107 A CLINICALLY RELEVANT HYBRID ADENOVIRUS- TRANSPOSON VECTOR FOR GENE THERAPY FOR VON WILLEBRAND DISEASE
€2.42 Add to cart
Article: A-107 DIFFERENCES IN HEPARIN AND ENOXAPARIN SENSITIVITY OF THREE COMMERCIALLY AVAILABLE PT REAGENTS
€2.42 Add to cart
Article: A-108 Belgian multicenter study into von Willebrand Disease (B-Will Study): First results
€2.42 Add to cart
Article: A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY
€2.42 Add to cart
Article: A-108 N-ACETYLCYSTEINE IN PRECLINICAL ANIMAL MODELS OF THROMBOTIC THROMBOCYTOPENIC PURPURA
€2.42 Add to cart
Article: A-109 A PATIENT WITH ACQUIRED FACTOR X DEFICIENCY AND METASTATIC TRANSITIONAL CELL CARCINOMA OF THE BLADDER : IS THERE A LINK BETWEEN METASTASIS AND FACTOR DEFICIENCY IN SOLID TUMOURS?
€2.42 Add to cart
Article: A-109 UNRESTRAINED ENDOGENOUS PLASMIN ACTIVITY REVERSES ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA
€2.42 Add to cart
Article: A-111 CLOPIDOGREL PREVENTS COLITIS-ASSOCIATED CARCINOGENESIS IN MICE BY INHIBITING IMMUNOSUPPRESSIVE FUNCTION OF IMMATURE MYELOID CELLS
€2.42 Add to cart
Article: A-111 IMPACT OF A RAPID CENTRIFUGATION METHOD ON THE ACCURACY OF DIRECT ORAL ANTICOAGULANTS LEVEL AND TURNAROUND TIME
€2.42 Add to cart

Article: A-103 SYSTEMIC THROMBOLYSIS AND ENDOVASCULAR THROMBECTOMY IN SEVERE ACUTE ISCHEMIC STROKE AFTER DABIGATRAN REVERSAL WITH IDARUCIZUMAB

Article: A-103 VALIDATION OF A CHROMOGENIC ASSAY FOR FVIII: C AND FIX: C (CSA) MEASURING AND COMPARISON WITH A CHRONOMETRIC ASSAY (OSA)

Article: A-104 THE INTERACTION OF FACTOR V AND TISSUE FACTOR PATHWAY INHIBITOR IN A MYELOMA PATIENT WITH ACQUIRED FACTOR V DEFICIENCY

Article: A-105 PEAR1: a novel link between IgE-mediated allergy and cardiovascular disease

Article: A-105 PRE-ANALYTICAL STABILITY OF COAGULATION PARAMETERS IN PLASMA STORED AT ROOM TEMPERATURE

Article: A-105 THE ROLE OF VON WILLEBRAND FACTOR IN A MALARIA-ASSOCIATED LUNG PATHOLOGY MODEL

Article: A-106 DABIGATRAN ETEXILATE IN THE TREATMENT OF LOCALIZED INTRAVASCULAR COAGULOPATHY ASSOCIATED WITH VENOUS MALFORMATIONS

Article: A-107 A CLINICALLY RELEVANT HYBRID ADENOVIRUS- TRANSPOSON VECTOR FOR GENE THERAPY FOR VON WILLEBRAND DISEASE

Article: A-107 DIFFERENCES IN HEPARIN AND ENOXAPARIN SENSITIVITY OF THREE COMMERCIALLY AVAILABLE PT REAGENTS

Article: A-108 Belgian multicenter study into von Willebrand Disease (B-Will Study): First results

Article: A-108 MONITORING ISSUES OF DIRECT ANTI-XA ORAL ANTICOAGULANTS AND LOW MOLECULAR WEIGHT HEPARINS, DURING BRIDGING WITH LMWH THERAPY

Article: A-108 N-ACETYLCYSTEINE IN PRECLINICAL ANIMAL MODELS OF THROMBOTIC THROMBOCYTOPENIC PURPURA

Article: A-109 A PATIENT WITH ACQUIRED FACTOR X DEFICIENCY AND METASTATIC TRANSITIONAL CELL CARCINOMA OF THE BLADDER : IS THERE A LINK BETWEEN METASTASIS AND FACTOR DEFICIENCY IN SOLID TUMOURS?

Article: A-109 UNRESTRAINED ENDOGENOUS PLASMIN ACTIVITY REVERSES ACUTE THROMBOTIC THROMBOCYTOPENIC PURPURA

Article: A-111 CLOPIDOGREL PREVENTS COLITIS-ASSOCIATED CARCINOGENESIS IN MICE BY INHIBITING IMMUNOSUPPRESSIVE FUNCTION OF IMMATURE MYELOID CELLS

Article: A-111 IMPACT OF A RAPID CENTRIFUGATION METHOD ON THE ACCURACY OF DIRECT ORAL ANTICOAGULANTS LEVEL AND TURNAROUND TIME